MEDICINES COMPANY v. HOSPIRA, INC. (Fed. Cir. 2016) (P, en banc) – Manufacturing services by a supplier does not trigger an on sale bar under 35 U.S.C. § 102(b)

The mere sale of manufacturing services by a contract manufacturer to an inventor to create embodiments of a patented product for the inventor does not constitute a “commercial sale” of the invention. Here, for example, no on sale bar was found to be triggered by the...

MERCK & CIE v. WATSON LABORATORIES INC. (Fed. Cir. 2016) (P) – It is not necessary that an actual sale be consummated to trigger the on-sale bar under 35 U.S.C. § 102(b)

While an offer for sale must qualify as a commercial offer under the law of contracts to trigger the on-sale bar under 35 U.S.C. § 102(b), it is not necessary that an actual sale ever be consummated. Here, for example, a fax detailing price and delivery terms,...

THE MEDICINES COMPANY v. HOSPIRA, INC. (Fed. Cir. 2015) (P) – Products prepared by a supplier for commercial exploitation by the patentee trigger the on-sale bar

Products embodying the invention and prepared by a supplier for commercial exploitation by the patentee trigger the on-sale bar. Here, for example, a batch of pharmaceuticals marked by the supplier with commercial product codes and customer lot numbers and sent to the...